Insulin resistance evaluated by metabolic syndrome, estimated glucose disposal rate, and visceral fat analysis in young adults with type 1 diabetes: A case control study - 21/11/26
, M. Yazidi, Pr, Z. Rekaya, Dr, E. Azouz, Dr, S. Hadj Taieb, Pr, H. Mizouni, Pr, M. Chihaoui, PrRésumé |
Introduction |
Insulin resistance (IR) is often underrecognized in young adults with type 1 diabetes (T1D). The aims of this study were to determine the prevalence of IR in young adults with T1D and the associated factors.
Methods |
We conducted a case-control study involving 68 patients with T1D and 68 healthy controls matched for age, sex, and body mass index, aged between 18 and 45 years. We assessed metabolic syndrome (MS) parameters, estimated Glucose Disposal Rate (eGDR), and body fat distribution using dual X-ray absorptiometry (DXA) in both patients and controls.
Results |
MS was more frequent in T1D patients (20.6% vs. 8.8%, p = 0.05). eGDR was lower in patients with T1D (8.3 ± 1.7 vs. 10.7 ± 1.4 mg/kg/min, p < 0.001). Visceral fat mass proportion (%VFM) was higher in controls (0.61 (0.37–1.21) vs. 0.47 (0.32–0.74), p = 0.05). In T1D patients, higher socioeconomic level ( p = 0.039), absence of physical activity ( p = 0.006) and diabetic retinopathy ( p = 0.011) were associated with MS. The absence of physical activity ( p = 0.005), diabetic retinopathy ( p = 0.014) and higher HbA1c level ( p < 0.001) were associated with low eGDR ( < 7.4 mg/Kg/min). Older age ( p = 0.031), absence of physical activity ( p = 0.05), and higher CRP level ( p = 0.02) were associated with high %VFM. After adjusting for HbA1c level and diabetes duration, diabetic retinopathy was independently associated with MS ( p = 0.025, ORa = 5.2, 95% CI [1.2–22.2]) and low eGDR ( p = 0.018, ORa = 8.3, 95% CI [1.4–48.6]).
Conclusion |
The prevalence of IR was high in young adults with T1D. It is associated with an increased risk of diabetic retinopathy, independent of HbA1c level.
Le texte complet de cet article est disponible en PDF.Plan
Vol 87 - N° 5
Article 103108- septembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
